CSRT.L Share News (CSRT)

CSRT.L Information

There is currently no data for CSRT

Consort Medical Signs VapourSoft Development Agreement With Regeneron

Fri, 18th Oct 2019 08:13

(Alliance News) - Consort Medical PLC on Friday said it has signed a contract with Regeneron Pharmaceuticals Inc, a biopharmaceutical company, to develop VapourSoft.

VapourSoft facilitates delivery of a broad range of drug formulations through the use of a liquid gas propellant.

The inhalation devices manufacturer said its proprietary VapourSoft technology will be incorporated into a novel drug delivery device designed by Regeneron.

If Regeneron elects to commercialise the developed device, Consort Medical said the parties will enter into a full commercial supply agreement with manufacturing to be undertaken by Consort for both the VapourSoft technology and the drug delivery device.

"We are delighted to be working with such a leading biotechnology innovator as Regeneron to develop novel devices for injectable drug delivery," said Consort Medical Chief Executive Jonathan Glenn.

"The agreement recognises the wide applicability of the VapourSoft technology as a power source for auto-injectors and the potential for incorporation into devices where conventional spring-based systems may not be suitable," added Glenn.

Consort Medical shares were trading 4.0% higher on Friday in London at 780.00 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

More News

30 Aug 2012 09:35

Thursday broker round-up

Admiral: Nomura keeps buy rating and 1,300p target. Antofagasta: Jefferies raises target from 1,050p to 1,200p, hold rating kept. APR Energy: Investec upgrades from hold to buy, target cut from 1,100p to 950p. Cape: Investec maintains buy recommendation and 300p target. Consort Medical: N+1 Brew

12 Jun 2012 08:20

Tuesday broker round-up

Amlin: Deutsche Bank upgrades to buy, target lifted from 420p to 435p. British Sky Broadcasting: Morgan Stanley upgrades to overweight, 790p target maintained. Consort Medical: Canaccord Genuity maintains buy rating and 744p target. easyJet: HSBC downgrades to neutral, target cut from 580p to 530

30 Apr 2012 10:03

Consort Medical gets US thumbs up

Consort Medical said the first product to use its built-in dose counter had been given the go-ahead by the US Food and Drug Administration. Consort's Integrated Dose Counter (IDC) is being used in Teva's QNASL nasal aerosol, which treats of nasal seasonal allergy symptoms. The firm had been develo

21 Feb 2012 12:07

Margins squeezed in Dechra's Services business

Veterinary pharmaceutical firm Dechra Pharmaceuticals saw a slight fall in interim pre-tax profits and a softening of gross margins in its Services division in the second half of 2011. Profit before tax in the six months to December 31st 2011 dropped to £8.9m from £9m the year before, on revenues o

13 Dec 2011 15:39

Whitbread chief keeps the faith

Whitbread chief executive Andy Harrison made a firm declaration of his faith in the firm, purchasing nearly £200,000-worth of shares on the same day the company admitted sales growth had slowed. The Costa Coffee and Premier Inn owner disappointed investors after the figures suggested that even the

17 Jun 2011 06:32

Friday tips round-up: Premier Farnell, Victoria, Sodastream

Premier Farnell's share price had risen by more than 50% since the start of 2010 before yesterday's 9% fall, so a correction was probably inevitable as soon as the electronics distributor undershot the market's forecasts. Though Asian markets such as China, sales up 14%, and India, up 50%, continue

16 Jun 2011 14:28

Healthy product pipeline for Consort Medical

Drug inhaler maker Consort Medical reported a higher full-year pretax profit and said it expects continued revenue and profit growth, partly driven by the launch of the King Vision and growing demand in its Bespak respiratory business. For the year ended April 30, revenue rose 7% to £126.8m, while

15 Mar 2011 06:55

Tuesday tips round-up: Aggreko, Bovis, Consort Medical...

Aggreko, the temporary power provider, saw its shares climb 5.5% amid expectations that it will be called in to help supply electricity to Japan's embattled population following the devastating earthquake and tsunami. The company said it stood ready to equip the country with self-contained gas and

7 Feb 2011 13:46

Consort backs diagnostics firm

Drug inhaler firm Consort Medical has formed a strategic alliance with Atlas Genetics, a UK-based healthcare technology company with a point of care (POC) diagnostics platform. Consort's Bespak division will undertake design for manufacture work to prepare the disposable test cards that are a core

3 Dec 2010 06:45

Friday tips round-up: Domino's Pizza, Britvic, Kingfisher...

The last two cold snaps boosted like-for-like sales at Domino's Pizza as peckish consumers, wary of slippery pavements, decided to phone for fast food. Domino's was ready to meet the challenge with its fleet of scooters, which made inroads in areas where larger vehicles were held back by the snow.

2 Dec 2010 10:29

Small caps round-up: Geong, Orosur Mining, XG Technology...

Chinese software and internet solutions provider Geong reported a 28% slump in turnover for the six months ended 30 September to £4.7m, though profits rose 17% to £0.7m. Chief executive Wang Weidong called it a "satisfactory" set of interim results and said the company expects full-year numbers to

9 Aug 2010 16:40

Capital reinvestment by chief exec

Ian Hawksworth has used cash raised from the sale of options exercised in Capital Shopping Centres to reinvest in Capital & Counties Properties. Hawksworth, who is chief executive of Capital & Counties, bought 87,840 shares at 112.99p each. That cost just over £99,000 and took his stake in the cen

1 Jul 2010 08:52

UK MARKET TALK ROUNDUP: SHARES GAINING

Stocks on the rise in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markettalk.eu@dowjones.com 0752 GMT [Dow Jones] Jefferies starts Consort Medical (CSRT.LN) at buy with a 525p target. Says Consort's Bespak business

1 Jul 2010 08:52

MARKET TALK: Jefferies Starts Consort Medical At Buy

0752 GMT [Dow Jones] Jefferies starts Consort Medical (CSRT.LN) at buy with a 525p target. Says Consort's Bespak business now has a much broader product pipeline, while the restructuring of the King Systems business should bear fruit. In addition to this, expects Consort to continue to be on the ac

18 Jun 2010 14:46

TechMARK movers: Oxford Biomedica amends antigen licence

Gene therapy company Oxford Biomedica has agreed an amendment to its licence with Cancer Research Technology covering the 5T4 antigen used in the Tro-Vax cancer vaccine. The deal covers royalties due to CRT relating to the sanofi-aventis TroVax agreement (signed March 2007 and terminated April 200

Latest Share Chat

CSRT.L Share News (CSRT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical Signs VapourSoft Development Agreement With Regeneron

Login to your account

Quickpicks are a member only feature

Login to your account